Same Indication

Ipilimumab vs Urea C 14

Ipilimumab vs Urea C 14: Overview

This comparison examines the pharmacological differences between Ipilimumab and Urea C 14.

Mechanism of Action

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Pharmacokinetics

Half-life: Ipilimumab — 14.7 days.

Chemical Properties

Type: Ipilimumab — Antibody; Urea C 14 — Small molecule.